Commentary: 5 ways industry can help the FDA improve

10/12/2011 | Xconomy

The FDA might need support from the biotech and drug sectors as the agency seeks to improve its processes for reviewing medical products, columnist Luke Timmerman writes. Timmerman breaks down five ways that the industry can take part in restoring public confidence in the agency, including showing support for an FDA budget increase and banning advisory-panel members with conflicts of interest.

View Full Article in:

Xconomy

Published in Briefs: